Washington [US], November 22 (ANI): A new study has found that people who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors (a class of immunosuppressants), generated less powerful and shorter-lived antibodies against the virus that causes COVID-19 than healthy people and those on other kinds of immunosuppressants.
\
\
